Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1983268

ENTRECTINIB
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1

Basic Information

ChEMBL ID CHEMBL1983268
Name ENTRECTINIB
Phase Approved
Structure Type MOL
InChI Key HAYYBYPASCDWEQ-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Entrectinib NMS-E628 Rozlytrek Rxdx-101
74
Targets
194
Activities
4
Assay Types
29
PK Parameters
20
Publications
4
Known Names
10
Indications
3
Mechanisms

Molecular Properties

560.6
MW (Da)
5.03
ALogP
6
HBA
3
HBD
85.5
PSA (Ų)
0.29
QED
2
Ro5 Violations
7
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2019
Availability Prescription
Chirality Achiral

Routes of Administration

Oral
USAN Stem -tinib
USAN Year 2015

Extended Properties

Molecular Formula C31H34F2N6O2
MW 560.65
Aromatic Rings 4
Heavy Atoms 41
NP-Likeness -1.35

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Neurotrophic tyrosine kinase receptor inhibitor INHIBITOR Neurotrophic tyrosine kinase receptor
Proto-oncogene tyrosine-protein kinase ROS inhibitor INHIBITOR Proto-oncogene tyrosine-protein kinase ROS
ALK tyrosine kinase receptor inhibitor INHIBITOR ALK tyrosine kinase receptor

Indications

Carcinoma, Non-Small-Cell Lung Neoplasms Neoplasms Carcinoma, Lobular Hematologic Neoplasms Melanoma Thyroid Neoplasms Glioma Leukemia, Myeloid, Acute Uveal Melanoma

ATC Classification

L01EX14
entrectinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS

Activity Summary

IC50 133 meas. best 9.7
Ki 56 meas. best 9.0
Kd 4 meas. best 8.7
EC50 1 meas. best 5.61

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Proto-oncogene tyrosine-protein kinase ROS
CHEMBL5568
IC50 9.7 8.2622 0.2 9
High affinity nerve growth factor receptor
CHEMBL2815
IC50 9.66 8.6363 0.2 19
ALK tyrosine kinase receptor
CHEMBL4247
Ki 9.0 8.605 1.0 2
BDNF/NT-3 growth factors receptor
CHEMBL4898
IC50 9.0 8.5767 1.0 9
NT-3 growth factor receptor
CHEMBL5608
IC50 9.0 8.451 1.0 10
ALK tyrosine kinase receptor
CHEMBL4247
IC50 8.8 7.5092 1.6 37
High affinity nerve growth factor receptor
CHEMBL2815
Ki 8.8 8.8 1.6 1
NT-3 growth factor receptor
CHEMBL5608
Ki 8.8 8.8 1.6 1
Leukocyte tyrosine kinase receptor
CHEMBL5627
Ki 8.8 8.8 1.6 1
KM12
CHEMBL614709
IC50 8.77 7.85 1.7 7
High affinity nerve growth factor receptor
CHEMBL2815
Kd 8.7 8.7 2.0 1
BDNF/NT-3 growth factors receptor
CHEMBL4898
Ki 8.6 8.6 2.5 1
Tyrosine-protein kinase Fer
CHEMBL3982
Ki 8.3 8.3 5.0 1
Tyrosine-protein kinase FRK
CHEMBL4223
Ki 7.8 7.8 15.8 1
Tyrosine-protein kinase JAK2
CHEMBL2971
Ki 7.7 7.7 19.9 1
SU-DHL-1
CHEMBL2366200
IC50 7.7 7.7 20.0 1
NON-PROTEIN TARGET
CHEMBL3879801
IC50 7.62 7.34 24.0 5
EML4-ALK
CHEMBL3883330
IC50 7.55 6.9233 28.0 3
KARPAS-299
CHEMBL2366156
IC50 7.51 7.315 31.0 2
Proto-oncogene tyrosine-protein kinase Src
CHEMBL267
Ki 7.5 7.5 31.6 1
Activated CDC42 kinase 1
CHEMBL4599
Ki 7.5 7.5 31.6 1
Serine/threonine-protein kinase PLK4
CHEMBL3788
Ki 7.4 7.4 39.8 1
Macrophage colony-stimulating factor 1 receptor
CHEMBL1844
Ki 7.4 7.4 39.8 1
Tyrosine-protein kinase JAK2
CHEMBL2971
IC50 7.4 7.4 40.0 1
Proto-oncogene tyrosine-protein kinase receptor Ret
CHEMBL2041
Ki 7.4 7.4 39.8 1
Tyrosine-protein kinase receptor UFO
CHEMBL4895
Ki 7.4 7.4 39.8 1
Unchecked
CHEMBL612545
IC50 7.39 7.02 41.0 3
Insulin-like growth factor 1 receptor
CHEMBL1957
Ki 7.2 7.2 63.1 1
NCI-H2228
CHEMBL1075536
IC50 7.17 6.9767 68.0 3
Activated CDC42 kinase 1
CHEMBL4599
IC50 7.16 7.16 70.0 1
MV4-11
CHEMBL613835
IC50 7.09 7.09 81.0 1
Focal adhesion kinase 1
CHEMBL2695
Ki 7.0 7.0 100.0 1
Tyrosine-protein kinase JAK1
CHEMBL2835
IC50 6.95 6.95 112.0 1
Insulin-like growth factor 1 receptor
CHEMBL1957
IC50 6.91 6.6625 122.0 4
Focal adhesion kinase 1
CHEMBL2695
IC50 6.85 6.85 140.0 1
STE20-like serine/threonine-protein kinase
CHEMBL4202
Ki 6.8 6.8 158.5 1
Tyrosine-protein kinase BTK
CHEMBL5251
Ki 6.8 6.8 158.5 1
Mast/stem cell growth factor receptor Kit
CHEMBL1936
Ki 6.8 6.8 158.5 1
Fibroblast growth factor receptor 3
CHEMBL2742
Ki 6.8 6.8 158.5 1
Receptor-type tyrosine-protein kinase FLT3
CHEMBL1974
IC50 6.79 6.79 164.0 1
Protein-tyrosine kinase 6
CHEMBL4601
IC50 6.71 6.71 195.0 1
Dual specificity protein kinase CLK4
CHEMBL4203
Ki 6.7 6.7 199.5 1
Vascular endothelial growth factor receptor 3
CHEMBL1955
Ki 6.7 6.7 199.5 1
Tyrosine-protein kinase Lyn
CHEMBL3905
Ki 6.7 6.7 199.5 1
Tyrosine-protein kinase Blk
CHEMBL2250
Ki 6.7 6.7 199.5 1
Insulin receptor
CHEMBL1981
IC50 6.68 6.68 209.0 1
Aurora kinase A
CHEMBL4722
IC50 6.67 6.52 215.0 4
Macrophage-stimulating protein receptor
CHEMBL2689
Ki 6.6 6.6 251.2 1
Aurora kinase A
CHEMBL4722
Ki 6.6 6.6 251.2 1
Fibroblast growth factor receptor 1
CHEMBL3650
Ki 6.6 6.6 251.2 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 10988.74 ng.hr.mL-1 Mus musculus
AUC 9755.31 ng.hr.mL-1 Mus musculus
AUC 8465.81 ng.hr.mL-1 Rattus norvegicus
AUC 2876.13 ng.hr.mL-1 Rattus norvegicus
AUC 9867.44 ng.hr.mL-1 Canis lupus familiaris
AUC 3195.7 ng.hr.mL-1 Canis lupus familiaris
CL 33.0 mL.min-1.kg-1 Homo sapiens
CL 87.0 mL.min-1.kg-1 Rattus norvegicus
CL 13.5 mL.min-1.kg-1 Mus musculus
CL 20.8 mL.min-1.kg-1 Rattus norvegicus
CL 17.5 mL.min-1.kg-1 Canis lupus familiaris
Cmax 4900.0 nM Mus musculus
Cmax 1330.0 nM Mus musculus
Cmax 11000.0 nM Rattus norvegicus
Cmax 500.0 nM Rattus norvegicus
Cmax 8600.0 nM Canis lupus familiaris
Cmax 600.0 nM Canis lupus familiaris
F 77.0 % Mus musculus
F 43.0 % Rattus norvegicus
F 32.0 % Canis lupus familiaris
T1/2 3.59 hr Mus musculus
T1/2 2.94 hr Mus musculus
T1/2 3.5 hr Rattus norvegicus
T1/2 3.8 hr Rattus norvegicus
T1/2 11.9 hr Canis lupus familiaris
T1/2 15.2 hr Canis lupus familiaris
Tmax 2.5 hr Mus musculus
Tmax 3.08 hr Rattus norvegicus
Tmax 2.0 hr Canis lupus familiaris

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Proto-oncogene tyrosine-protein kinase ROS IC50 = 0.2 nM 9.7 Inhibition of ROS1 (unknown origin) 35033885
High affinity nerve growth factor receptor IC50 = 0.22 nM 9.66 Inhibition of human wild type TrkA kinase domain expressed in mouse NIH/3T3 cell... 31444087
High affinity nerve growth factor receptor IC50 = 0.6 nM 9.22 Enzyme Assay: In each well of a 384-well plate, 1 nM-1.5 nM of wild type NTRK1 e... -
High affinity nerve growth factor receptor IC50 = 0.6 nM 9.22 NTRK1 Wild Type Assay at 1 mM ATP: In each well of a 384-well plate, 1 nM-1.5 nM... -
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of wild type TRAK (unknown origin) incubated for 30 mins by caliper m... 33069129
ALK tyrosine kinase receptor Ki = 1.0 nM 9.0 PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member na... -
NT-3 growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TRKC (unknown origin) 37413881
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TRKA (unknown origin) 38852338
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TRKA (unknown origin) by TR-FRET assay 36095945
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TRKA (unknown origin) by radiometric assay 35007864
BDNF/NT-3 growth factors receptor IC50 = 1.0 nM 9.0 Inhibition of TrkB (unknown origin) 35033885
NT-3 growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TrkC (unknown origin) 35033885
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TrkA (unknown origin) 35033885
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TrkA (unknown origin) by radiometric assay 34253025
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TRKA (unknown origin) by radiometric assay 34628036
High affinity nerve growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of TRKA (unknown origin) in presence of gamma33-ATP 27003761
High affinity nerve growth factor receptor Ki = 1.585 nM 8.8 PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member na... -
Leukocyte tyrosine kinase receptor Ki = 1.585 nM 8.8 PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member na... -
NT-3 growth factor receptor Ki = 1.585 nM 8.8 PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member na... -
ALK tyrosine kinase receptor IC50 = 1.6 nM 8.8 Inhibition of ALK (unknown origin) 35033885

Literature References

PubMed DOI Target Context # Activities
27003761 10.1021/acs.jmedchem.6b00064 Unchecked 52
27003761 10.1021/acs.jmedchem.6b00064 Mus musculus 19
27003761 10.1021/acs.jmedchem.6b00064 Canis familiaris 10
27003761 10.1021/acs.jmedchem.6b00064 Rattus norvegicus 10
- 10.6019/CHEMBL5303304 U2OS 9
- 10.6019/CHEMBL5303304 HEK-293T 8
27003761 10.1021/acs.jmedchem.6b00064 NON-PROTEIN TARGET 7
- 10.6019/CHEMBL5303304 Fibroblast 7
27003761 10.1021/acs.jmedchem.6b00064 Tropomyosin alpha-3 chain/High affinity nerve growth factor receptor 5
37030091 10.1016/j.ejmech.2023.115291 High affinity nerve growth factor receptor 4
27003761 10.1021/acs.jmedchem.6b00064 ADMET 4
27003761 10.1021/acs.jmedchem.6b00064 NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) 4
29191878 10.1126/science.aan4368 Unchecked 4
31444087 10.1016/j.bmcl.2019.126624 High affinity nerve growth factor receptor 3
27003761 10.1021/acs.jmedchem.6b00064 EML4-ALK 3
27003761 10.1021/acs.jmedchem.6b00064 Proto-oncogene tyrosine-protein kinase ROS 2
27003761 10.1021/acs.jmedchem.6b00064 High affinity nerve growth factor receptor 2
27003761 10.1021/acs.jmedchem.6b00064 BDNF/NT-3 growth factors receptor 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
27003761 10.1021/acs.jmedchem.6b00064 ALK tyrosine kinase receptor 2

Data from ChEMBL 36 via Core Engine